Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi
Palliative Medicine Reports · 2026-01 · 7
DOI: 10.1177/26892820261431682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Palliative Medicine Reports, online erschienen am 03.08.2026. Verfasst von Alyssa E Tilly und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: School of Medicine, University of North Carolina at Chapel Hill.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Lymphoma is one of the most common cancers affecting young adults in Sub-Saharan Africa, yet survival outcomes lag far behind those in high-resource settings. A significant contributor to these disparities is treatment abandonment, driven by limited access to essential palliative care support and lack of symptom management medications. This study aimed to assess the feasibility and early uptake of a Symptom Toolkit intervention to support symptom recognition and self-management.
Methods
We designed and implemented a novel, low-cost, culturally appropriate Symptom Toolkit into an oncology clinic in Malawi. The toolkit included nurse-delivered patient education and take-home essential therapies targeting high-burden symptoms, including pain, nausea and vomiting, insomnia, gastritis, mucositis, and constipation, with pictorial labels and a journal to record use. Included therapies were selected based on local clinical guidelines and availability. At follow-up visits, a palliative care nurse completed survey assessments and distributed new Symptom Toolkits, noting both symptom occurrence and rates of medication use.
Results
A total of 65 patients with lymphoma (median age 39) participated, including individuals with acute lymphoblastic leukemia, Burkitt lymphoma, diffuse large B-cell lymphoma, and Hodgkin’s lymphoma. Across the 602 toolkit reports completed, use of symptom-directed medications increased over time, indicating improved uptake and engagement with the intervention.
Conclusions
This pilot intervention demonstrates the feasibility of a nurse-delivered Symptom Toolkit as a means to enhance symptom recognition and self-management in a low-resource oncology setting. Further evaluation of the Toolkit in future studies will assess its impact on symptom burden and quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA.
- Department of Pediatrics, UNC School of Medicine, Chapel Hill, North Carolina, USA.
- UNC Project-Malawi, Lilongwe, Malawi.
- Department of Pediatric Hematology/Oncology, Roger Maris Cancer Center, Fargo, North Dakota, USA.
- Department of Pediatric Hematology/Oncology, St Luke's Cancer Institute, Boise, Idaho, USA.
- Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Alyssa E Tilly
Förderung
- School of Medicine, University of North Carolina at Chapel Hill
Zitieren
APA
Tilly, A. E., Evans, A., Chikasema, M., Chen, J. S., Kleber, S., & Westmoreland, K. (2026). Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi. Palliative Medicine Reports, 7. https://doi.org/10.1177/26892820261431682
Vancouver
Tilly AE, Evans A, Chikasema M, Chen JS, Kleber S, Westmoreland K. Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi. Palliative Medicine Reports. 2026;7. doi:10.1177/26892820261431682
BibTeX
@article{Tilly2026,
author = {Tilly, Alyssa E and Evans, April and Chikasema, Maria and Chen, Jane S and Kleber, Selena and Westmoreland, Katherine},
title = {Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi},
journal = {Palliative Medicine Reports},
year = {2026},
volume = {7},
doi = {10.1177/26892820261431682}
}
EUVIMED